1Wang TJ,Larson MG,Levy D,et al.Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality:the Framingham Heart Study[J].Circulation,2003,107:2920-2925.
2Van den Berg MP,Van Gelder IC,Van Veldhuisen DJ.Impact of atrial fibrillation on mortality in patients with chronic heart failure[J].Eur J Heart Fail,2002,4:571-575.
3Cleland JG,Caletta AP,Abdellah AT,et al.Clinical trials update from the American Heart Association 2007:CORONA,RethinQ,MASCOT,AF-CHF,HART,MASTER,POISE and stem cell therapy[J].Eur J Heart Failure,2008,10:102-108.
4Pedersen OD,Bagger H,Keller N,et al.Efficacy of dofetilide in the treatment of atrial fibriUatian-flutter in patients with reduced left ventricular function:a Danish Investigations of Arrhythmia and Mortality On Dofetilide (DIAMOND) substudy[J].Circulation,2001,104:292 -296.
5Olshansky B,Rosenfeld LE,Warner AL,et al.The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)study:approaches to control rate in atrial fibrillation[J].J Am Coll Cardiol,2004,43:1201-1208.
6Fonarow GC,Lukas MA,Robertson M,et al.Effects of carvedilol early after myocardial infarction:analysis of the first 30 days in Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction(CAPRICORN)[J].Am Heart J,2007,154:637-644.
7Deedwania PC,Singh BN,Ellenbogen K,et al.Spontaneous conversion and maintenance of sinus rhythm by amiedarone in patients with heart failure and atrial fibrillation:observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy(CHF-STAT)[J].Circulation,1998,98:2574 -2579.
8Mclrd AH ,Esocobar C, Rellb JM ,et al.Angiotensin receptor blocker as adjunctive therapy forrhytm control in atrial fibrillation;results of the irbesartam amiodrone trial[J].Card Electrophyslol rev,2003,7:242.
